Prelude Capital Management’s NeoGenomics NEO Stock Holding History

Prelude Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,810	Closed	-$54K	–	2144
2019 Q3	$54K	Buy	+2,810	New	+$65.9K	﹤0.01%	1140
2019 Q1	–	Sell	-404	Closed	-$5K	–	2026
2018 Q4	$5K	Buy	+404	New	+$6.02K	﹤0.01%	1617
2014 Q3	–	Sell	-7,500	Closed	-$25K	–	2032
2014 Q2	$25K	Buy	+7,500	New	+$24.9K	﹤0.01%	1681

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Prelude Capital Management's NEO Position: Q4 2019 in Review

Prelude Capital Management sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 2,810 shares — an estimated $54K sold.

Prelude Capital Management first reported a position in NEO in Q2 2014 and held it in 3 quarters. The position peaked at $54K in Q3 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

Prelude Capital Management reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
Prelude Capital Management sold 2,810 NeoGenomics shares in Q4 2019, an estimated $54K.
Prelude Capital Management first reported a position in NeoGenomics in Q2 2014 and held it in 3 quarters.
Prelude Capital Management's NeoGenomics position peaked at $54K in Q3 2019.
261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.